Tezspire 210 MG/1.91 ML pen 1.91ML
Ended Awarded
- Contract number
- SPE2DB25FG7LX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,687
Award facts
- Contract value 100% obligated
- $4,687.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,687.18 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of TEZSPIRE 210 mg/1.91 mL pen injectors, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside contract is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
TEZSPIRE is a specialty biologic medication used for treating moderate-to-severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps, representing the type of specialized pharmaceutical commodity that AmerisourceBergen routinely delivers through its federal contract portfolio. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, AmerisourceBergen maintains extensive capabilities to fulfill federal medical procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order exemplifies the company's role in supporting Defense Health Agency and broader military healthcare operations through flexible contract vehicles designed to meet evolving pharmaceutical supply needs.
Quick answers
Who was awarded contract SPE2DB25FG7LX?
SPE2DB25FG7LX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 16, 2025.
How much is contract SPE2DB25FG7LX worth?
The government has obligated $4,687 on SPE2DB25FG7LX.
Is contract SPE2DB25FG7LX an order under another contract?
Yes. SPE2DB25FG7LX is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FG7LX competed?
The extent of competition for SPE2DB25FG7LX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award